Socialized Medicine Threatens Dignity, Promotes Assisted Suicide

4 min read

Canada’s socialized medicine system has long been criticized for its shortcomings, including long wait times, drug rationing, and substandard care. These systemic failures have led to dire consequences for patients, such as the case of Allison Ducluzeau, a Canadian native who was diagnosed with stage 4 peritoneal carcinomatosis in 2022. Her oncologists in British Columbia informed her that she was not eligible for the surgery she needed, and chemotherapy was unlikely to be effective. With a prognosis of two months to two years, her doctors suggested she consider assisted suicide.

A Life Saved by American Medicine

Allison refused to accept this grim prognosis. Within days, she reached out to two American hospitals willing to treat her cancer. She traveled to Mercy Medical Center in Baltimore, Maryland, where Dr. Armando Sardi provided her with the medical care she needed. By November 2023, she was not only cancer-free but also on her honeymoon, having married in a dream wedding. This stark contrast highlights the differences between the American and Canadian healthcare systems. Mercy Medical Center treated Allison with medical precision and dignity, while the British Columbia Cancer Agency failed to provide the same level of care.

These differences are emblematic of the broader issues with socialized medicine. The Canadian system is characterized by shortages, long wait times, and a lack of access to life-saving treatments. Patients like Allison are often forced to consider assisted suicide when the system fails to provide adequate care. The article argues that assisted suicide is not a compassionate solution but a systemic failure of socialized medicine. It is a coercive measure that undermines human dignity and pushes the most vulnerable patients toward euthanasia.

The Spread of Assisted Suicide in the U.S.

The United States is moving closer to a similar reality. As of now, 13 states and the District of Columbia have legalized assisted suicide. Since 1997, nearly 15,000 Americans have died by assisted suicide, with annual figures increasing by 1000% between 2014 and 2024. In California alone, 378 doctors prescribed 1,839 lethal drugs in 2025, resulting in the deaths of 1,235 patients. Over 90% of those who died were over the age of 60, and the majority suffered from cancer.

Despite the growing number of states allowing assisted suicide, only 13 states and the District of Columbia currently permit it. However, 17 states are actively considering legislation to legalize it. If these states succeed, 31 U.S. jurisdictions will allow assisted suicide, with out-of-state patients able to seek it in Oregon and Vermont. This expansion of assisted suicide raises serious concerns about the future of healthcare in the U.S.

The Role of Drug Pricing Policies

The push for drug pricing plans that tie U.S. prices to foreign systems like the Most Favored Nations (MFN) approach is a major concern. The MFN model matches U.S. drug prices to European nations, which use Quality-Adjusted Life Years (QALYs) to set prices. This system scores drugs based on their likelihood of producing “perfect health” in patients, often excluding those for rare diseases, chronic illnesses, and terminal conditions. This approach risks importing socialist drug rationing to the U.S., leading to the denial of life-saving treatments for the most vulnerable.

While American families seek relief from high drug costs, tying U.S. prices to those of foreign systems is not a morally neutral policy choice. It risks importing the anti-American assumptions and mechanisms of those systems, including bureaucratic gatekeeping, delayed access, and quality-of-life judgments that reject the inherent dignity of all human life.

Public Concern Over Drug Pricing Policies

A recent poll by Concerned Women for America found that over 54% of respondents “somewhat” or “strongly” oppose tying U.S. prescription drug prices to countries where the government controls drug prices by limiting access to treatments based on the government’s perceived value of a person’s life. This reflects a growing public concern about the ethical implications of such policies.

America was founded on the promise of life, liberty, and the pursuit of happiness for all, including the terminally ill, cancer patients, individuals with chronic or rare diseases, the elderly, the disabled, and everyone a Parisian bureaucrat might consider “not worth the investment.” Rationing life-saving drugs away from vulnerable Americans who need them most is not the solution to high drug prices. It leaves them with nothing but assisted suicide.

The Ethical and Moral Implications

When assisted suicide becomes the norm and real care is an exception, death loses dignity and gains a dangerous price tag. Denying medicine to vulnerable people and euthanizing not only the terminally ill but also the chronically ill, mentally ill, minors, the elderly, and the disabled is unethical and immoral. The United States must renew its commitment to life, liberty, and the pursuit of happiness for all.

Socialized medicine, under the guise of “lower prices,” is not the answer to high drug prices in the United States. Our nation must stop assisted suicide in its tracks and fight for opportunity and dignity for all.

Source: Daily Wire

Written by

Connor Davis